The FDA has approved the remote programming of cochlear implants via a telemedicine platform, freeing patients with severe to profound hearing loss from the need to visit specialized centers to get ...
The U.S. Food and Drug Administration today approved a remote feature for follow-up programming sessions for the Nucleus Cochlear Implant System through a telemedicine platform. The remote programming ...
(RTTNews) - Cochlear Limited has received FDA approval in September for the company's Cochlear Remote Assist solution in the Nucleus and Baha Systems. Cochlear noted that the FDA approval for the ...
LONE TREE, Colo., Oct. 12, 2021 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval and clearance ...
Amid COVID-19 uncertainty and patent battle loss, Cochlear raises AU$880M, rolls out remote solution
PERTH, Australia – Cochlear Ltd., of Sydney, is gearing up to launch its new Remote Check solution for cochlear implant users on the heels of an AU$880 million (US$559 million) capital raise and a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results